Electroconvulsive Therapy Intervention for Parkinson’s Disease

Innovations in Clinical Neuroscience

Puneet Narang¹  Steven Lippmann¹  Anna Glowacki¹ 

[1] Dr. Narang is Assistant Professor with the University of Minnesota and Staff Physician and Lead ECT Psychiatrist at Regions Hospital, Minneapolis-St. Paul, Minnesota; Dr. Glowacki is a first year family medicine resident at John Peter Smith hospital, Fort Worth Texas; and Dr. Lippmann is Professor of Psychiatry at University of Louisville School of Medicine, Louisville, Kentucky

关键词: Electroconvulsive therapy;    ECT;    Parkinson’s disease;    motor symptoms;    “on-off” phenomenon;   

DOI  :  

学科分类：精神健康和精神病学

来源: Matrix Medical Communications, LLC

【 摘 要 】

Background: Electroconvulsive therapy is an established means to improve function in a variety of psychiatric and neurologic conditions, particularly for patients who remain treatment-refractory. Parkinson’s disease is a neurodegenerative disorder that sometimes does not respond well to conventional pharmacotherapies. Reports have indicated that electroconvulsive therapy may be an effective and safe treatment for those patients with Parkinson’s disease who are not optimally responding to first-line treatments. Despite these reports, however, electroconvulsive therapy is not often used by clinicians in patients with treatment-resistant Parkinson’s disease, perhaps due to stigma, lack of knowledge regarding its safety and efficacy, and/or inability to predict the duration of therapeutic benefit.

【 授权许可】

Unknown